MS Speaks

Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on April 08, 2018, 04:27:28 pm

Title: More risks emerge for alemtuzumab in MS
Post by: agate on April 08, 2018, 04:27:28 pm

From MedPage Today, "More risks emerge for alemtuzumab in MS" (April 6, 2018):


https://www.medpagetoday.com/neurology/multiplesclerosis/72194?xid=nl_mpt_DHE_2018-04-07&eun=g345846d0r&pos=0&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-04-07&utm_term=Daily%20Headlines%20-%20Active%20User%20-%20180%20days